Prescription Drugs Number of Medicare Term Paper

The Act creates a positive balance between government interests to save money and the interests of Medicare recipients to receive a wide range of drugs for their specific needs. The current ban on government negotiations with pharmaceutical companies serves to protect Medicate recipients by using the positives of the free market, such as the experience and purchasing power of PBMs. While there are serious potential problems with this approach, such as the potential for fraud between pharmaceutical companies and private interests, overall the ban on government negotiations with pharmaceutical companies provides a good balance between recipient and government interests.

Works Cited

American Legislative Exchange Council. Prescription Drugs. 19 October 2005. http://www.alec.org/2/4/talking-points/7.html

Barry, Patricia. New Salvos in the Prescription Drug Wars: Class action suits are exposing schemes that gouge consumers.AARP Bulletin, January 2005.

19 October 2005. http://www.aarp.org/bulletin/prescription/a2005-01-06-salvos.html

Dealey, Sam. Drug Dealings: Democrats had it right before. National Review Online, May 05, 2004, 9:12 A.M. 19 October 2005. http://www.nationalreview.com/comment/dealey200405050912.asp

Haislmaier, Edmund F. Compromising Quality: The High Cost of Government Drug Purchasing

The Heritage Foundation Backgrounder #1764, May 25, 2004. 19 October 2005. http://www.heritage.org/Research/HealthCare/bg1764.cfm

Kaiser Family Foundation. Prescription Drug Costs. 19 October 2005. http://www.kff.org/rxdrugs/7175.cfm

Office of Legislative Policy and Analysis. 2003. Session I - P.L. 108-173 - Medicare Prescription Drug, Improvement, and Modernization Act of 2003. 19 October 2005. http://olpa.od.nih.gov/actions/public/108session1/pl108-173.asp.....